-
BI 2536: Reading PLK1 Checkpoint Biology
2026-08-27
BI 2536 is a selective PLK1 inhibitor that can reveal how mitotic arrest, checkpoint disassembly, and apoptosis are mechanistically connected. This article translates the p31comet–PLK1 study into a deeper framework for interpreting cancer research assays and tumor models.
-
AmpliFold Capture-and-Release for LFA Sensitivity
2026-08-27
The ChemRxiv study introduces AmpliFold, a triggered capture-and-release strategy that uses cleavable protein linkers and dual-affinity gold nanoparticles to improve lateral flow assay sensitivity. In a HER2 model, expanding the capture area and tuning receptor density produced up to 16-fold improvement in detection performance, including a 12-fold enhancement with 150 nm nanoparticles in buffer and human serum.
-
CCT007093: PPM1D Inhibitor Workflows
2026-08-26
CCT007093 is a research-use PPM1D inhibitor for connecting phosphatase activity with early P38 kinase activation, cell viability, and inflammatory cell-death readouts. Its strongest use is an orthogonal workflow that combines biochemical testing, timed phospho-P38 analysis, viability measurements, and pathway-rescue controls.
-
Tunicamycin as an ER Stress Assay Compass
2026-08-26
Tunicamycin is a powerful N-glycosylation inhibitor for dissecting how ER stress reshapes endothelial inflammation. This guide translates recent ATF6–TRIM10–NF-κB findings into practical assay design, controls, and interpretation strategies.
-
CB-5083 p97 Inhibitor Workflows in Cancer Research
2026-08-25
CB-5083 converts p97 biology into a practical workflow for measuring protein homeostasis disruption, stress signaling, and cancer cell apoptosis induction. This guide links biochemical target engagement with cell-based assays, cGAS–DNA repair studies, and tumor growth inhibition in xenograft models while emphasizing reproducible handling and troubleshooting.
-
Resiniferatoxin (RTX) Research Workflows
2026-08-25
Resiniferatoxin (RTX) enables precise TRPV1-driven studies of pain, calcium signaling, and sensory nerve desensitization. This workflow-focused guide covers in vitro screening, joint-localized analgesia models, route selection, assay controls, and troubleshooting for translating RTX findings across experimental systems.
-
Z-VAD-FMK Workflows for Apoptosis Research
2026-08-24
Use Z-VAD-FMK as a mechanistic control to determine whether mitochondrial or immune-cell stress is caspase dependent, rather than relying on a single viability endpoint. This practical workflow covers stock handling, dose-response design, orthogonal readouts, AML-focused applications, and troubleshooting for reproducible apoptosis inhibition.
-
KN-62 Workflow for CaMKII Signaling Studies
2026-08-24
Build cleaner CaMKII experiments with KN-62 by separating kinase-dependent effects from direct calcium-channel pharmacology. This practical workflow connects secretion, glucose transport, and cell-cycle assays with electrophysiology-informed controls and troubleshooting.
-
Dual-Action Inhibitors Reprogram p38α Dephosphorylation
2026-08-23
A 2024 preprint shows that selected kinase inhibitors can do more than occupy the p38α catalytic site: they can also accelerate WIP1-mediated removal of the activation-loop phosphothreonine. Structural and biochemical results identify kinase-conformation control as a potential route to stronger, more selective inhibition of p38 MAPK signaling pathway activity.
-
Sodium Ascorbate: From ROS to Translation
2026-08-22
Sodium Ascorbate offers a mechanistically defined redox perturbation for cancer models, while emerging biomarker research shows why future translation must connect tumor-cell stress with immune and microenvironmental context.
-
Polybrene: Gene Delivery Workflow & Troubleshooting
2026-08-21
Polybrene (Hexadimethrine Bromide) improves viral gene delivery and can rescue lipid-mediated DNA transfection in difficult cell lines. This practical guide connects controlled reagent optimization with assay design for mutant-p53 research while clearly separating established product uses from emerging applications.
-
Demethyleneberberine: From Mechanism to Translation
2026-08-20
Demethyleneberberine offers translational researchers a mechanism-rich platform spanning inflammation, autoimmunity, neuroprotection, and NSCLC research. This article interprets the evidence, defines practical experimental parameters, and outlines how to move from pathway observations to reproducible model development.
-
P-Glycoprotein Inhibition Boosts Luteolin Bioavailability
2026-08-20
The reference study develops a luteolin-loaded self-microemulsifying drug delivery system that combines improved solubilization with inhibition of intestinal P-glycoprotein efflux. Its integrated cellular, pharmacokinetic, and safety data show a 29-fold increase in luteolin exposure, while also identifying clathrin- and caveolae-mediated uptake as important contributors.
-
N1-Methyl-Pseudouridine-5'-Triphosphate in IVT
2026-08-19
A scenario-based guide to using N1-Methyl-Pseudouridine-5'-Triphosphate in modified-RNA workflows that feed cell viability, proliferation, and cytotoxicity assays. It explains how SKU B8049 supports controlled in vitro transcription, interpretation of cell responses, and practical reagent selection.
-
EZ Cap Cy5 Firefly Luciferase mRNA Guide
2026-08-19
EZ Cap Cy5 Firefly Luciferase mRNA is a dual-reporter transcript for separating mRNA delivery from protein expression. Its Cy5 label supports fluorescence tracking, while Firefly luciferase supports translation readouts and in vivo bioluminescence imaging under appropriate substrate and delivery conditions.